AMERICAN SOCIETY OF CLINICAL ONCOLOGY for AMERICAN SOCIETY OF CLINICAL ONCOLOGY
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 1844, Comprehensive Cancer Care Improvement Act, seeking cosponsors
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BLACKWELL | — |
| SHELAGH FOSTER | — |
Medicare/Medicaid MMM
H.R. 1392 and S. 1221- an act to ensure more appropriate payment for drugs under Medicaer Part B; seeking cosponsors Medicare Reimbursement for Chemotherapy Drugs H.R. 3095, Medicare Cancer Patient Database and Coverage Act, seeking cosponsors SGR Repeal, advocacy for the repeal and temporary SGR extension (H.R. 3962, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BLACKWELL | — |
| SHELAGH FOSTER | — |
Budget/Appropriations BUD
General Appropriations issues related to cancer research, the National Institutes of Health, the National Cancer Institute, and the Food and Drug Administration S. 3686 FY 2011 Labor, HHS, Education, and Related Agencies Appropriations Bill H.R. 3081 FY 2011 Continuing Resolution October 1-December 3, 2010
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BLACKWELL | — |
| SHELAGH FOSTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.